FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

CVM Draft Guide on CMC Technical Section

[ Price : $8.95]

FDA releases a CVM draft guidance entitled Chemistry, Manufacturing, and Controls (CMC) Technical Section Filing Strategies.

Apple Watch Cleared for Assessing Sleep Apnea

[ Price : $8.95]

FDA clears an Apple 510(k) for its Apple Watch to be used as an over-the-counter device for assessing the risk of sleep apnea.

Boehringer Ingelheim Plans Pulmonatry Fibrosis NDA

[ Price : $8.95]

Boehringer Ingelheim plans an NDA for nerandomilast for treating idiopathic pulmonary fibrosis (IPF) after reporting that its Phas...

Fresenius Recalls Ivenix Pump Administration Sets

[ Price : $8.95]

Fresenius Kabi recalls (Class 1) one lot of the Ivenix Large Volume Pump primary administration sets after documenting a manufactu...

Clinical Hold Lifted on Zentalis Azenosertib

[ Price : $8.95]

FDA removes a partial clinical hold on Zentalis Pharmaceuticals azenosertib studies into the drugs use against solid tumors and tw...

New Electronic Common Technical Document Version

[ Price : $8.95]

Federal Register notice: FDA announces its support for Electronic Common Technical Document Version 4.0 (v4.0)-based electronic su...

Subcutaneous Tecentriq Hybreza Approved

[ Price : $8.95]

FDA approves a subcutaneous injectable formulation of Genentechs Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) for all t...

FDA Corrects ANDA Approval Withdrawals from 6/21

[ Price : $8.95]

Federal Register notice: FDA corrects a notice that appeared in the 6/21 Federal Register announcing the approval withdrawal 20 AN...

Expanded Approval for Dupixent in Rhinosinusitis

[ Price : $8.95]

FDA grants expanded approval for Regeneron Pharmaceuticals and Sanofis Dupixent (dupilumab) as an add-on maintenance treatment for...

Lillys Ebglyss Approved for Eczema

[ Price : $8.95]

FDA approves an Eli Lilly BLA for Ebglyss (lebrikizumab-lbkz) for treating adults and children 12 years of age and older with mode...